SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 337 participants.
Also called NCT02439775
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 337 participants
- Sponsor
- Registry
-
NCT02439775
-
- Other papers using this trial's data
- Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED
- Long-Term Safety and Efficacy of Renal Denervation: 24-Month Results From the SPYRAL HTN-ON MED Trial
- Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications
- Three-Year Durability of Radiofrequency Renal Denervation: SPYRAL HTN-ON MED
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Austria, Canada, France, Germany, Greece, Ireland, Japan, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02439775. Randomized; single masking; primary purpose treatment. Start 2015-07-22 (actual); primary completion 2022-08-18 (actual). Results posted on 2023-09-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System
- Condition
- Hypertension
- Condition
- Vascular Diseases
- Condition
- Cardiovascular Diseases
- Intervention (Device)
- Symplicity Spyral™ multi-electrode renal denervation system
- Intervention (Procedure)
- Sham Procedure
- Lead sponsor
- Medtronic Vascular
Record details
- Record id
cardio:ct-nct02439775- Content hash
b3c100312a8a8c4be4e6bd9a0735b9b1fa2b8a384fc9f43f904f4ec56eb66fa7